NEVVI Medicare utilization intelligence

← back

SIDDIQUE, KHAWAJAMD NPI 1750636635 Clinician

Family Practice · GLEN COVE, NY

Specialty Family Practice — from billed Medicare claims
In practice about 22 years since medical school (class of 2004, self-reported to CMS)
Location GLEN COVE, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 46 codes billed · 4,116 disclosed services (CY2024 — most recent year in data)
Current groups
member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026
KIM MEDICAL OF NEW YORK PLLC
2024–2026
CITY MEDICAL OF UPPER EAST SIDE PLLC
2019–2026
AMERICAN MEDICAL TODAY PC
2021

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-05

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1836 Injection, metronidazole, 10 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J0696 Injection, ceftriaxone sodium, per 250 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99349 Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes
87804 Detection test by immunoassay with direct visual observation for influenza virus
87428 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza
99350 Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes
36415 Insertion of needle into vein for collection of blood sample
96360 Infusion into a vein for hydration, 31-60 minutes
G0318 Prolonged home or residence evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualif
J0692 Injection, cefepime hydrochloride, 500 mg
81003 Automated urinalysis test
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
99344 Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)
J7050 Infusion, normal saline solution, 250 cc
J7030 Infusion, normal saline solution , 1000 cc
96361 Infusion into a vein for hydration, each additional hour
J1335 Injection, ertapenem sodium, 500 mg
J1940 Injection, furosemide, up to 20 mg
99348 Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes
96375 Injection of additional new drug or substance into vein
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
94640 Inhalation treatment for airway obstruction or sputum production
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus
99342 Residence visit for new patient with low level of medical decision making, per day, if using time, at least 30 minutes
51701 Insertion of temporary bladder tube
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
71046 X-ray of chest, 2 views
71101 X-ray of ribs on side of body, minimum of 3 views
99497 Advance care planning, first 30 minutes
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days
99345 Residence visit for new patient with high level of medical decision making, per day, if using time, at least 75 minutes
73562 X-ray of knee, 3 views
96374 Injection of drug or substance into vein
99453 Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment
82962 Blood glucose (sugar) test performed by hand-held instrument
99458 Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.